extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd
- Factual accuracy — The claims appear factually correct, with new evidence supporting or challenging existing claims regarding GLP-1s' cost-effectiveness and multi-organ benefits. 2.…
extract: 2026-03-01-cvleconomics-creator-owned-platforms-future-media-work
Approved (post-rebase re-approval).
extract: 2026-02-01-glp1-patent-cliff-generics-global-competition
- Factual accuracy — The additional evidence provided in the claim about GLP-1 receptor agonists introduces new information regarding generic competition and its potential impact on…
extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd
Here's my review of the PR:
- Factual accuracy — The claims and entities appear factually correct based on the provided evidence. The new evidence in both claims accurately reflects…
extract: 2024-12-02-futardio-proposal-approve-deans-list-treasury-management
Approved (post-rebase re-approval).